Bhalerao-Gandhi Ashwini, Chhabra Pankdeep, Arya Saurabh, Simmerman James Mark
P. D. Hinduja Hospital and Medical Research Centre, Veer Savarkar Marg, Mahim, Mumbai 400016, India.
Sanofi Pasteur India Pvt. Ltd., 54/A, Mathuradas Vasanji Road, Andheri East, Mumbai 400093, India.
Infect Dis Obstet Gynecol. 2015;2015:867587. doi: 10.1155/2015/867587. Epub 2015 Feb 24.
Maternal influenza infection is known to cause substantial morbidity and mortality among pregnant women and young children. Many professional healthcare bodies including the World Health Organization (WHO) have identified pregnant women as a priority risk group for receipt of inactivated seasonal influenza vaccination. However influenza prevention in this group is not yet a public health priority in India. This literature review was undertaken to examine the Indian studies of influenza among pregnant women. Eight Indian studies describing influenza burden and/or outcomes among pregnant women with influenza were identified. In most studies, influenza A (pH1N1) was associated with increased maternal mortality (25-75%), greater disease severity, and adverse fetal outcomes as compared to nonpregnant women. Surveillance for seasonal influenza infections along with higher quality prospective studies among pregnant women is needed to quantify disease burden, improve awareness among antenatal care providers, and formulate antenatal influenza vaccine policies.
众所周知,孕妇感染流感会导致严重的发病和死亡,尤其是在孕妇和幼儿群体中。包括世界卫生组织(WHO)在内的许多专业医疗保健机构已将孕妇确定为接种季节性流感灭活疫苗的重点风险人群。然而,在印度,该群体的流感预防尚未成为公共卫生重点。本次文献综述旨在研究印度关于孕妇流感的研究。共确定了八项描述流感孕妇负担和/或结局的印度研究。在大多数研究中,与未怀孕女性相比,甲型流感(pH1N1)与孕产妇死亡率增加(25%-75%)、疾病严重程度更高以及不良胎儿结局相关。需要对季节性流感感染进行监测,并在孕妇中开展更高质量的前瞻性研究,以量化疾病负担,提高产前护理提供者的认识,并制定产前流感疫苗政策。